Kim R Y, Cooper K L, Kelly L D
Massachusetts Eye & Ear Infirmary, USA.
Graefes Arch Clin Exp Ophthalmol. 1996 Dec;234(12):731-8. doi: 10.1007/BF00189353.
Fifty-four consecutive cases of culture-positive bacterial ulcerative keratitis presenting at a major university hospital were reviewed to identify factors predictive of response to medical therapy for bacterial ulcerative keratitis (BUK).
Eleven patients (20%) failed medical therapy (defined as the need for surgical intervention or cyanoacrylate gluing). Using multivariate logistic regression, the following variables were evaluated: (1) predisposing ocular factors (e.g., contact lens wear), (2) pre-existing ocular diseases, (3) ulcer size, and (4) the number of topical ocular medications used at the time of presentation.
We noted certain factors to be potentially predictive of medical therapy outcome. The average size of the ulcer at the time of presentation was 4.4 +/- 2.4 mm in the failure group but only 2.5 +/- 1.9 mm for the success group (P = 0.027). In addition, patients in the medical failure group used more topical ocular medications at the time of presentation (P = 0.0075). Further analysis of the individual topical ocular medications revealed that the use of corticosteroids was higher in the failure group (56% vs 12%, P = 0.0005 by Fisher's exact test). Other factors such as patient age, the type of organism(s), and the time elapsed between the onset of symptoms and the beginning of definitive therapy were not statistically significant.
In this population, ulcer size at the onset of antibacterial treatment and the use of certain ocular medications, specifically corticosteroids, were significant predictive factors for failure of medical therapy for BUK.
回顾了一所大型大学医院连续收治的54例培养阳性的细菌性溃疡性角膜炎病例,以确定预测细菌性溃疡性角膜炎(BUK)药物治疗反应的因素。
11例患者(20%)药物治疗失败(定义为需要手术干预或氰基丙烯酸酯粘合)。使用多因素逻辑回归分析,评估以下变量:(1)诱发眼部因素(如佩戴隐形眼镜),(2)既往眼部疾病,(3)溃疡大小,以及(4)就诊时使用的局部眼部药物数量。
我们注意到某些因素可能预测药物治疗结果。就诊时溃疡的平均大小在失败组为4.4±2.4mm,而成功组仅为2.5±1.9mm(P = 0.027)。此外,药物治疗失败组的患者在就诊时使用了更多的局部眼部药物(P = 0.0075)。对个别局部眼部药物的进一步分析显示,失败组中皮质类固醇的使用比例更高(56%对12%,Fisher精确检验P = 0.0005)。其他因素,如患者年龄、病原体类型以及症状出现至开始确定性治疗之间的时间间隔,差异无统计学意义。
在该人群中,抗菌治疗开始时的溃疡大小以及某些眼部药物(特别是皮质类固醇)的使用是BUK药物治疗失败的重要预测因素。